Tag: giant cell arteritis (GCA)

FDA OK’s Roche’s arteritis drug
May 25, 2017 Off

FDA OK’s Roche’s arteritis drug

By Dino Mustafić

The U.S. Food and Drug Administration (FDA) has approved Roche’s Actemra/RoActemra (tocilizumab) subcutaneous injection for the treatment of GCA, a chronic and severe autoimmune condition.